Carlsbad California

Roche’s $1.8B GenMark deal brings a key testing capability for Covid-19 and beyond

Roche already sells a Covid-19 diagnostic. In acquiring GenMark Diagnostics for $1.8B, Roche is adding technology that can detect SARS-CoV-2 along with multiple respiratory diseases in a single test from a single patient sample---a capability the Swiss multinational company does not currently offer.

By Frank Vinluan

BioPharma

FDA guides approval of Ionis and Biogen’s new SMA therapy

Ionis and Biogen have secured FDA approval for their spinal muscular atrophy drug, working closely with the FDA and tapping into a trifecta of incentives -- including fast-track designation, priority review and orphan drug designation.

By Juliet Preston

Closing the Quality-Affordability Gap in Workplace Mental Health

In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.

By Stephanie Baum

New Webinar: The Payer AI Readiness Gap: Why Better Data Will Define the Next Era of Health Plan Performance

We'll explore why the next era of payer performance will depend on building a trusted data foundation that connects people, providers, and relationships across the enterprise.

By Verato and MedCity News

Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork

By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®